New impact factor of Cancer Biology & Medicine: 5.432

According to the Journal Citation Reports (2020), the Impact Factor (2019) of Cancer Biology & Medicine is 5.432, locating in Q1 areas of both Medicine, Research & Experimental category (ranking 20/138) and Oncology category (ranking 52/244).

As a peer-reviewed open-access journal, Cancer Biology & Medicine is quarterly published by China Anti-Cancer Association and Tianjin Medical University Cancer Institute and Hospital. It focuses on translational cancer research, dedicating to narrowing the gap between bench and bedside. Except for SCIE, the journal has been indexed in PubMed/ PubMed Central, BIOSIS Previews, SCOPUS, DOAJ, and Chemical Abstracts. Meanwhile, it is also a member of the Committee on Publication Ethics (COPE) and CrossRef.

Welcome to submit your work to Cancer Biology & Medicine and communicate with your colleagues worldwide via our platform.

Contact us at editor@cancerbiomed.org

Journal web: www.cancerbiomed.org

Full text in PubMed Central: https://www.ncbi.nlm.nih.gov/pmc/journals/2000/

Online submission: https://mc03.manuscriptcentral.com/cbm

JCR website

Impact Factor

Ranking